Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/27/2002WO2002103371A2 Magnetic-based placement and retention of sensor elements in a sensor array
12/27/2002WO2002103361A1 Method for identification of agents for the treatment of diabetes
12/27/2002WO2002103352A1 Determination of pregnancy status
12/27/2002WO2002103351A1 Method of detecting skin stimulation effect
12/27/2002WO2002103343A1 Biosensor
12/27/2002WO2002103320A2 Diagnosis and prognosis of breast cancer patients
12/27/2002WO2002103060A2 Enterovirus nucleic acids and methods for detecting enterovirus
12/27/2002WO2002103059A2 Innate immunity markers for rapid diagnosis of infectious diseases
12/27/2002WO2002103058A2 Process for enhanced molecular target detection using layered rolling circle amplification
12/27/2002WO2002103056A1 Electrophoresis separation media and methods
12/27/2002WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION
12/27/2002WO2002103054A1 Genome walking by selective amplification of nick-translate dna library and amplification from complex mixtures of templates
12/27/2002WO2002103053A1 Method of efficiently detecting double-stranded nucleic acid
12/27/2002WO2002103052A1 Amplifiable probe
12/27/2002WO2002103051A2 Nucleic acid triplex and quadruplex formation
12/27/2002WO2002103050A2 Virus detection method, primers therefor and screening kit
12/27/2002WO2002103049A2 Screens for susceptibility to immunodeficiency and viral disease
12/27/2002WO2002103048A2 Real happy mapping
12/27/2002WO2002103047A2 Genomic mapping method
12/27/2002WO2002103046A2 Happier mapping
12/27/2002WO2002103045A2 Improvements in and relating to the provision of dna investigating tools
12/27/2002WO2002103044A1 Improved methods relating to amplification-based analysis of dna
12/27/2002WO2002103043A2 Method for the specific fast detection of bacteria which is harmful to beer
12/27/2002WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002WO2002103041A2 Method and nucleic acids for the differentiation of prostate and renal carcinomas
12/27/2002WO2002103040A1 Viral drug susceptibility testing
12/27/2002WO2002103039A1 A method for measuring dna polymerization and applications of the method
12/27/2002WO2002103038A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase
12/27/2002WO2002103037A1 Conductometric detection process
12/27/2002WO2002103036A1 An enzymatic method for rapid quantitation of oxidized reduced glutathione
12/27/2002WO2002103035A1 Improved method for assessing liver disease
12/27/2002WO2002103034A1 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
12/27/2002WO2002103032A2 Catalases, nucleic acids encoding them and methods for making and using them
12/27/2002WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002WO2002103028A2 In silico screening for phenotype-associated expressed sequences
12/27/2002WO2002103013A2 Partially double-stranded nucleic acids, methods of making, and use thereof
12/27/2002WO2002103011A2 Selective gene amplification
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002WO2002103007A1 Method of uniformizing dna fragment contents and subtraction method
12/27/2002WO2002103003A1 Lipid-modified enzymes, process for producing the same and biosensor
12/27/2002WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002WO2002103000A2 Methods for modulating gap junctions
12/27/2002WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002WO2002102980A2 Kits and methods for assessing leptin-mediated lipid matabolism
12/27/2002WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102855A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
12/27/2002WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102853A2 Cd4-specific antibody trx1 and uses therefor
12/27/2002WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002WO2002102834A2 Synthetic sensor peptide for the detection and/or measurement of kinase or phosphate activity of proteins
12/27/2002WO2002102828A2 Chimeric flavivirus vectors
12/27/2002WO2002102824A2 Method for specific fast detection of relevant bacteria in drinking water
12/27/2002WO2002102768A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
12/27/2002WO2002102523A1 Method and apparatus for solid state molecular analysis
12/27/2002WO2002102368A1 Mass cell production method of chondrocytes, using an erk activity inhibitor, and a screening method therefor
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102300A2 Diagnostics and therapeutics for glaucoma retinal degenerative diseases and cardiovascular diseases based on novel nucleic acid and protein forms of myocilin (myoc)
12/27/2002WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002WO2002102232A2 A novel signaling pathway for the production of inflammatory pain and neuropathy
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002102144A1 Cell deah-inducible model nonhuman animal
12/27/2002WO2002095036A3 A novel intein and uses thereof
12/27/2002WO2002092199A8 Detection of cells using molecular electrophoretic change
12/27/2002WO2002070662A3 Three hybrid assay system
12/27/2002WO2002070658A9 Compositions and methods for increasing amino acid absorption in mammals
12/27/2002WO2002064618A3 Methods of identifying agents that mediate polypeptide aggregation
12/27/2002WO2002057766A3 Thick film conductor composition for use in biosensors
12/27/2002WO2002057415A3 Method for altering cell fate
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056888A3 Assay method, tnf modulator and its use
12/27/2002WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002046751A9 Methods of predicting chemotherapy response
12/27/2002WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
12/27/2002WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
12/27/2002WO2002038799A3 Detection of proteases and screening for protease inhibitors
12/27/2002WO2002038795A3 Braf35 protein and brca2/braf35 complex and methods of use
12/27/2002WO2002033120A3 Non-invasive prenatal monitoring
12/27/2002WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002WO2002012467A3 Drug metabolizing enzymes
12/27/2002WO2002012279A3 Schizophrenia related gene and protein
12/27/2002WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
12/27/2002WO2002006500A3 Methods of transforming plants and identifying parental origin of a chromosome in those plants
12/27/2002WO2002004667A3 Improved detection signal and capture in dipstick assays
12/27/2002WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002WO2002004122A3 Improved stability of hybridisation interactions in dipstick assays
12/27/2002WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/27/2002WO2001094587A3 Extracellular messengers
12/27/2002WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002WO2001085986A3 Phosphatidyl inositol 3-kinase delta binding partner
12/27/2002WO2001085937A3 Regulator of g protein signalling (rgs8)
12/27/2002WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
12/27/2002WO2001081628A9 Nucleic acid sequences associated with baldness
1 ... 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 ... 3003